# Foghorn Therapeutics Inc. (FHTX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/FHTX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 3.27M | $ -19.88M | $ -25.27M | $ 41.99M | $ -76.41M |
| 2025 | $ 31.65M | $ -76.06M | $ -88.21M | $ 41.27M | $ -108.50M |
| 2024 | $ 23.76M | $ -91.04M | $ -106.49M | $ 37.13M | $ -45.53M |
| 2023 | $ 36.93M | $ -106.42M | $ -129.03M | $ 45.07M | $ -77.19M |
| 2022 | $ 21.48M | $ -121.63M | $ 214.93M | $ 51.51M | $ 112.0K |
| 2021 | $ 1.57M | $ -120.43M | $ -63.67M | $ 58.33M | $ 96.87M |
| 2020 | $ 547.8K | $ -87.65M | $ -60.47M | $ 82.00M | $ 146.19M |
| 2019 | $ 0 | $ -65.99M | $ -61.06M | $ 16.63M | $ -88.02M |
| 2018 | $ 0 | $ -17.39M | $ -15.97M | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.55 |
| Liabilities / Eq | -3.91 |
| Current Ratio | 2.92 |

## Other views

- [Metrics](https://sponda.capital/en/FHTX.md)
- [Charts](https://sponda.capital/en/FHTX/charts.md)
- [Compare](https://sponda.capital/en/FHTX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.